A Beta-only IL-2 ImmunoTherapY Study
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre
- Status
- RECRUITING
- Phase
- NA
A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3811 Tablets in Patients With Advanced Malignant Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Pharmacokinetics Study of Famitinib Malate Capsules in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of LP-118 in Patients With Advanced Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation
- Status
- TERMINATED
- Phase
- PHASE2
Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation in China
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1